“The field as a whole, in the last 10 years, has gone incredibly fast to come up with innovative molecules to target KRAS” @kevansf @UCSF in #AACR25 Keynote | Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR ow.ly/UBT250VN3Z9 @AACR
